Tumorigenic and Differentiation Potentials of Embryonic Stem Cells Depend on TGF Family Signaling: Lessons from Teratocarcinoma Cells Stimulated to Differentiate with Retinoic Acid

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2017 Aug 12

PMID 28798778

Citations 13

Authors

Olga Gordeeva

Sergey Khaydukov

Affiliations

Soon will be listed here.

Abstract

A significant challenge for the development of safe pluripotent stem cell-based therapies is the incomplete in vitro differentiation of the pluripotent stem cells and the presence of residual undifferentiated cells initiating teratoma development after transplantation in recipients. To understand the mechanisms of incomplete differentiation, a comparative study of retinoic acid-induced differentiation of mouse embryonic stem (ES) and teratocarcinoma (EC) cells was conducted. The present study identified differences in proliferative activity, differentiation, and tumorigenic potentials between ES and EC cells. Higher expression of Nanog and Mvh, as well as Activin A and BMP4, was found in undifferentiated ES cells than in EC cells. However, the expression levels of Activin A and BMP4 increased more sharply in the EC cells during retinoic acid-induced differentiation. Stimulation of the Activin/Nodal and BMP signaling cascades and inhibition of the MEK/ERK and PI3K/Act signaling pathways resulted in a significant decrease in the number of Oct4-expressing ES cells and a loss of tumorigenicity, similar to retinoic acid-stimulated EC cells. Thus, this study demonstrates that a differentiation strategy that modulates prodifferentiation and antiproliferative signaling in ES cells may be effective for eliminating tumorigenic cells and may represent a valuable tool for the development of safe stem cell therapeutics.

Citing Articles

Reprogramming human urine cells into intestinal organoids with long-term expansion ability and barrier function.

Zhang R, Chen Y, Feng Z, Cai B, Cheng Y, Du Y Heliyon. 2024; 10(13):e33736.

PMID: 39040281 PMC: 11261862. DOI: 10.1016/j.heliyon.2024.e33736.

Recent Findings on Therapeutic Cancer Vaccines: An Updated Review.

Sheikhlary S, Lopez D, Moghimi S, Sun B Biomolecules. 2024; 14(4).

PMID: 38672519 PMC: 11048403. DOI: 10.3390/biom14040503.

Review on kidney diseases: types, treatment and potential of stem cell therapy.

Singh J, Singh S Ren Replace Ther. 2023; 9(1):21.

PMID: 37131920 PMC: 10134709. DOI: 10.1186/s41100-023-00475-2.

Mesenchymal stem-cell-derived microvesicles ameliorate MPTP-induced neurotoxicity in mice: a role of the gut-microbiota-brain axis.

Pu Y, Wu Q, Zhang Q, Huang T, Wen J, Wei L Psychopharmacology (Berl). 2023; 240(5):1103-1118.

PMID: 36881113 DOI: 10.1007/s00213-023-06348-0.

Archetypal Architecture Construction, Patterning, and Scaling Invariance in a 3D Embryoid Body Differentiation Model.

Gordeeva O, Gordeev A, Erokhov P Front Cell Dev Biol. 2022; 10:852071.

PMID: 35573693 PMC: 9091174. DOI: 10.3389/fcell.2022.852071.

References

Swijnenburg R, Schrepfer S, Govaert J, Cao F, Ransohoff K, Sheikh A . Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts. Proc Natl Acad Sci U S A. 2008; 105(35):12991-6. PMC: 2529073. DOI: 10.1073/pnas.0805802105. View

Tesarova L, Simara P, Stejskal S, Koutna I . The Aberrant DNA Methylation Profile of Human Induced Pluripotent Stem Cells Is Connected to the Reprogramming Process and Is Normalized During In Vitro Culture. PLoS One. 2016; 11(6):e0157974. PMC: 4919089. DOI: 10.1371/journal.pone.0157974. View

Strickland S, Mahdavi V . The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 1978; 15(2):393-403. DOI: 10.1016/0092-8674(78)90008-9. View

Takahashi K, Mitsui K, Yamanaka S . Role of ERas in promoting tumour-like properties in mouse embryonic stem cells. Nature. 2003; 423(6939):541-5. DOI: 10.1038/nature01646. View

Burridge P, Keller G, Gold J, Wu J . Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell. 2012; 10(1):16-28. PMC: 3255078. DOI: 10.1016/j.stem.2011.12.013. View

Gore A, Li Z, Fung H, Young J, Agarwal S, Antosiewicz-Bourget J . Somatic coding mutations in human induced pluripotent stem cells. Nature. 2011; 471(7336):63-7. PMC: 3074107. DOI: 10.1038/nature09805. View

Nagy A, Rossant J, Nagy R, Abramow-Newerly W, Roder J . Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A. 1993; 90(18):8424-8. PMC: 47369. DOI: 10.1073/pnas.90.18.8424. View

Toyooka Y, Tsunekawa N, Akasu R, Noce T . Embryonic stem cells can form germ cells in vitro. Proc Natl Acad Sci U S A. 2003; 100(20):11457-62. PMC: 208779. DOI: 10.1073/pnas.1932826100. View

Brederlau A, Correia A, Anisimov S, Elmi M, Paul G, Roybon L . Transplantation of human embryonic stem cell-derived cells to a rat model of Parkinson's disease: effect of in vitro differentiation on graft survival and teratoma formation. Stem Cells. 2006; 24(6):1433-40. DOI: 10.1634/stemcells.2005-0393. View

10.

Delacroix L, Moutier E, Altobelli G, Legras S, Poch O, Choukrallah M . Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol Cell Biol. 2009; 30(1):231-44. PMC: 2798310. DOI: 10.1128/MCB.00756-09. View

11.

Park I, Lerou P, Zhao R, Huo H, Daley G . Generation of human-induced pluripotent stem cells. Nat Protoc. 2008; 3(7):1180-6. DOI: 10.1038/nprot.2008.92. View

12.

Spira A, Carducci M . Differentiation therapy. Curr Opin Pharmacol. 2003; 3(4):338-43. DOI: 10.1016/s1471-4892(03)00081-x. View

13.

Bertacchi M, Lupo G, Pandolfini L, Casarosa S, DOnofrio M, Pedersen R . Activin/Nodal Signaling Supports Retinal Progenitor Specification in a Narrow Time Window during Pluripotent Stem Cell Neuralization. Stem Cell Reports. 2015; 5(4):532-45. PMC: 4624997. DOI: 10.1016/j.stemcr.2015.08.011. View

14.

Okita K, Ichisaka T, Yamanaka S . Generation of germline-competent induced pluripotent stem cells. Nature. 2007; 448(7151):313-7. DOI: 10.1038/nature05934. View

15.

Drukker M, Katchman H, Katz G, Even-Tov Friedman S, Shezen E, Hornstein E . Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells. Stem Cells. 2005; 24(2):221-9. DOI: 10.1634/stemcells.2005-0188. View

16.

Watabe T, Miyazono K . Roles of TGF-beta family signaling in stem cell renewal and differentiation. Cell Res. 2008; 19(1):103-15. DOI: 10.1038/cr.2008.323. View

17.

Laurent L, Ulitsky I, Slavin I, Tran H, Schork A, Morey R . Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell. 2011; 8(1):106-18. PMC: 3043464. DOI: 10.1016/j.stem.2010.12.003. View

18.

Chen F, Cai B, Gao Y, Yuan X, Cheng F, Wang T . Suicide gene-mediated ablation of tumor-initiating mouse pluripotent stem cells. Biomaterials. 2012; 34(6):1701-11. DOI: 10.1016/j.biomaterials.2012.11.018. View

19.

Gordeev O, Lifantseva N, Khaidukov S . [Expression patterns of germ line specific genes in mouse and human pluripotent stem cells are associated with regulation of ground and primed state of pluripotency]. Ontogenez. 2012; 42(6):403-24. View

20.

Lowry W, Richter L, Yachechko R, Pyle A, Tchieu J, Sridharan R . Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc Natl Acad Sci U S A. 2008; 105(8):2883-8. PMC: 2268554. DOI: 10.1073/pnas.0711983105. View